Get startedLog in
    Picture of China Medical System Holdings logo

    867 — China Medical System Holdings News Story

    0.000.00%
    hk flag iconLast trade - 00:00
    HealthcareAdventurousMid CapNeutral
    All News

    Brief: China Medical System Completes Dosing Of The First Subject In Phase Iii Bridging Trial

    Picture of China Medical System Holdings logoChina Medical System Holdings
    25/06/2024 11:28
    June 25 (Reuters) - China Medical System Holdings Ltd
 0867.HK :
    * CHINA MEDICAL SYSTEM COMPLETES DOSING OF THE FIRST SUBJECT
IN
PHASE III BRIDGING TRIAL OF RUXOLITINIB CREAM IN ATOPIC
DERMATITIS IN CHINA

Source text for Eikon:  ID:nGNX4yr2p6 
Further company coverage:  0867.HK 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on China Medical System Holdings

    See all news